Teva Triumphs Over Merck In Temodar Patent Spat
Judge Sue L. Robinson of the U.S. District Court for the District of Delaware sided with the generic-drug maker, which inherited the first filed abbreviated new drug application for the drug when it acquired rival Barr Pharmaceuticals Inc. in 2008.
Merck, which picked up an exclusive licensing agreement for the patent...
Already a subscriber? Click here to login